Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial – protocol for a phase II study

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial – protocol for a phase II study

Background Trans Tasman Radiation Oncology Group 20.01 CHEST-RT (Chemotherapy and Immunotherapy in Extensive Stage Small cell with Thoracic Radiotherapy) is a single-arm, open-label, prospective, multicentre phase II trial study that aims to establish the safety, feasibility and describe the efficac...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Mitchell, Christopher Oldmeadow, Sagun Parakh, Susan Harden, Melissa Moore, Lucy Leigh, Shalini Vinod, Catherine Bettington, Harriet Gee, Adeline Lim, Courtney Wheeler, Bridget Rooney, Rebecca Montgomery, Margot Lehman, Trevor Moodie, Jeffrey Barber, Laurel Schmidt, Jason Dizon, Eric Hau
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/7/e101571.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/7/e101571.full

Similar Items